Arteriovenous differences of hematological and coagulation parameters in patients with sepsis

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 8, 2010, Pages 770-774

  Durila, Miroslav ^a   Kalinčík, Tomáš ^b,c   Jurčenko, Sergej ^a   Pelichovská, Martina ^a   Hadačová, Ivana ^a   Cvachovec, Karel ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

antithrombin; arteriovenous difference; D dimer; hemostasis; sepsis; thromboelastography

Indexed keywords

ANTITHROMBIN; D DIMER; FIBRINOGEN;

ADULT; AGED; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; SCORING SYSTEM; SEPSIS; THROMBOELASTOGRAPHY; VENOUS BLOOD;

ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBINS; ARTERIES; BLOOD COAGULATION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; SEPSIS; THROMBELASTOGRAPHY; VEINS;

EID: 78349263824     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32834013d7     Document Type: Article

References (13)

1. Blann AD, Adams RA, Katai F, Ashleigh R, Taberner DA. Haematology and coagulation indices in paired samples of arterial and venous blood from patients with arterial disease. Haemostasis 1996; 26:72-78.
2. Woller T, Lawall H, Amann B, Angelkort B. Comparison of haemostatic parameters in arterial and venous blood from patients with peripheral arterial occlusive disease. Vasa 1999; 28:10-14.
3. Heap MJ, Ridley SA, Hodson K, Martos FJ. Are coagulation studies on blood sampled from arterial lines valid? Anaesthesia 1997; 52:640-645.
4. Ozsoylu S.Thecomparisonof thecoagulationfactorsin arterial andvenous blood. Acta Haematol 1969; 41:303-308.
5. Manspeizer HE, Imai M, Frumento RJ, Parides MK, Mets B, Bennett-Guerrero E. Arterial and venous thrombelastograph variables differ during cardiac surgery. Anesth Analg 2001; 93:277-281; 271st contents page.
6. Gonano C, Sitzwohl C, Meitner E, Weinstabl C, Kettner SC. Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis. Crit Care 2006; 10:R160.
7. Arcelus JI, Traverso CI, Caprini JA. Thromboelastography for the assessment of hypercoagulability during general surgery. Semin Thromb Hemost 1995; 21 (Suppl 4):21-26.
8. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27:81-90.
9. Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinolysis 2001; 12:327-337.
10. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655.
11. Dixon B. The role of microvascular thrombosis in sepsis. Anaesth Intensive Care 2004; 32:619-629.
12. Diaz NL, Finol HJ, Torres SH, Zambrano CI, Adjounian H. Histochemical and ultrastructural study of skelet al muscle in patients with sepsis and multiple organ failure syndrome (MOFS). Histol Histopathol 1998; 13:121-128.
13. Stief TW, Ijagha O, Weiste B, Herzum I, Renz H, Max M. Analysis of hemostasis alterations in sepsis. Blood Coagul Fibrinolysis 2007; 18:179-186.